Previous Article | Next Article ![]()
Journal of Virology, January 2006, p. 281-295, Vol. 80, No. 1
0022-538X/06/$08.00+0 doi:10.1128/JVI.80.1.281-295.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
ková,
Ji
í Nehyba,
Andrew S. Liss, and
Henry R. Bose Jr.*
Section of Molecular Genetics and Microbiology, School of Biological Sciences and Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, Texas 78712-1095
Received 20 August 2005/ Accepted 6 October 2005
Telomerase
is activated during the transformation of lymphoid cells and
fibroblasts by v-Rel, the oncogenic member of the Rel/NF-
B
family of transcription factors. v-Rel-transformed cell lines have
longer telomeres than untransformed chicken lymphoid cells and have
high levels of telomerase activity. v-Rel-mediated activation of
telomerase is achieved by multiple mechanisms. The expression of the
gene encoding the catalytic subunit of telomerase (TERT) was directly
upregulated by v-Rel. Moreover, the expression of v-Rel altered the
ratio of alternatively spliced and full-length TERT transcripts in
favor of the full-length forms. The activation of telomerase by v-Rel
in lymphocytes was also accompanied by inactivation of nuclear
inhibitors. The inhibition of telomerase activity in v-Rel-transformed
cell lines led to apoptosis within 24 h. The expression of
v-Rel in a macrophage cell line resulted in elevated levels of reactive
oxygen species (ROS), increased telomerase activity, and increased
sensitivity to telomerase inhibitors. In contrast, the ectopic
expression of TERT decreased the extent of apoptosis induced by ROS.
The activation of telomerase by v-Rel may, therefore, partially protect
the transformed cells from apoptosis induced by
ROS.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|